SUBSCRIBE
SUBSCRIBE

Pluristem Therapeutics Sees Positive Result for Stem Cell Therapy

September 14, 2010 | 
1 min read
TEL AVIV, Sept 14 (Reuters) - Pluristem Therapeutics (PSTI.O) said early clinical trials show its placenta-derived cell therapy is safe and improves quality of life in patients with degenerative disorder peripheral artery disease (PAD).
Asia
MORE ON THIS TOPIC
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Obesity
Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study
February 10, 2026
 · 
1 min read
 · 
Tristan Manalac
3d render scene
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
February 2, 2026
 · 
8 min read
 · 
Annalee Armstrong
Business people shaking hand in China.
Obesity
AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront
January 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Facade of AstraZeneca's office in Shanghai, China
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
January 29, 2026
 · 
1 min read
 · 
Tristan Manalac